Cell Impact AB (CI) Fair Value & Analysis
Industrials · SE · Market cap 63.3M SEK
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 3 days ago
Fair value updated Jun 26, 2026 — revised from kr 1.12 to kr 0.0600 (−94.6%) since Jun 24, 2026. Share price −25.3% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 0.0756 – kr 0.5976 · fair‑value band kr 0.0400 – kr 0.0700 · the kr 0.1040 price screens above the kr 0.0600 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Cell Impact AB (CI) currently trades at kr 0.1040, while our model-based Fair Value estimate is kr 0.0600 — implying the stock looks roughly 42.3% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 5.9M SEK. Revenue grew 10.4% year over year. It earns a return on equity of -80.7%. Net debt stands at 21.7M SEK. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company provides production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was incorporated in 1999 and is headquartered in Karlskoga, Sweden.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Cell Impact AB reported revenue of kr 5.6M in FY2025 versus kr 71.3M in FY2021, a compound −47.1%/yr. Reported net income was −kr 132M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Metal Fabrication stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| ATI Inc ATI | $204.09 | $36.39 | -82% |
| Carpenter Technology Corporation CRS | $492.62 | $82.57 | -83% |
| Mueller Industries, Inc MLI | $139.51 | $120.61 | -14% |
| Aurubis AG NDA | €216.20 | €116.94 | -46% |
| Commercial Metals Company CMC | $73.57 | $28.97 | -61% |
| China International Marine Containers (Group) Co 000039 | ¥8.98 | ¥12.75 | +42% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Cell Impact AB (CI) undervalued?
What is the fair value of CI?
What is the quality score of CI?
What is the revenue of Cell Impact AB (CI)?
What is the net profit margin of CI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.